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ABSTRACT 
 
Research has focused extensively on the negative health effects of inadequate Mg intake, 
but the extent of the problem of deficiency deserves further exploration. The notion that U.S. 
adults consume an inadequate amount of magnesium, leading to increased risk for chronic 
diseases such as depression, is plausible. National Health and Nutrition Examination Surveys 
(NHANES), which are large, cross-sectional, population-based data sets that assess the health and 
nutritional status of U.S. adults and children, indicate over half the adult population does not 
consume adequate amounts of magnesium based on the estimated average requirement (EAR) 
established by the Institute of Medicine. Using 2007 to 2010 NHANES data we found 54% of 
adults do not meet the EAR, confirming results from earlier surveys. As a result of this finding, a 
review exploring the factors impacting magnesium consumption over time and the adequacy of 
current intake in U.S. adults was conducted. Changes in agricultural processes that reduce 
magnesium levels in crops combined with the increasing consumption of processed foods 
containing little to no magnesium have led to a decrease in mean daily intake by 200-300 mg per 
day over the past century. However, population-based studies show a steady and consistent 
recovery in magnesium intake in U.S. adults over the past several decades. A simple, rapid, 
accurate test for whole body Mg status is lacking and, although population-based studies have 
limitations, continued monitoring of Mg consumption is essential to determine whether this 
positive trend continues. In the meantime, since the health consequences of inadequate 
magnesium are well established, there are no reported cases of hypermagnesemia from food 
alone, and magnesium is found in healthy foods adults should consume more often, there are few 
reasons not to encourage increased magnesium intake.  
 
Cross-sectional and prospective trials in other countries report an association between 
magnesium intake and symptoms of depression. Depression is a chronic disease affecting a 
significant portion of the U.S. population. Magnesium plays a role in many of the pathways 
involved in the pathophysiology of depression and is found in several enzymes, hormones, and 
neurotransmitters. Depression and magnesium are both associated with systemic inflammation. 
Current treatment options for depression are limited by efficacy, cost, availability, side effects, 
and acceptability to patients. As a result of the need for additional treatment options, interest in 
the role of magnesium in modulating depressive symptoms has grown. We used the NHANES 
2007-2010 data to examine this relationship in U.S. adults and found a significant association 
between very low magnesium intake and symptoms of depression (RR=1.16; 95% confidence 
interval (CI) 1.06, 1.30; P=0.03). Whether inadequate magnesium leads to increased risk for 
depression or depression results in poor dietary intake is not known. 
 
To test whether supplementation with over-the-counter magnesium chloride improves 
symptoms of depression, an open-label, blocked, randomized, cross-over trial was carried out in 
outpatient primary care clinics on 126 adults (mean age 52; 38% male) diagnosed with, and 
currently experiencing, mild-to-moderate symptoms. Consumption of magnesium chloride tablets 
for 6 weeks resulted in a clinically significant net improvement in depression (Patient Health 
Questionnaire-9) scores of -6.0 points (95% CI -7.9, -4.2; P<0.001) and net improvement in 
anxiety (Generalized Anxiety Disorders-7) scores of -4.5 points (95% CI -6.6, -2.4; P<0.001). 
Effects were observed regardless of age, gender, baseline magnesium levels, baseline severity of 
depression, or use of antidepressant treatments. It worked quickly, was well tolerated, and is 
much safer and less expensive than conventional treatments with medication. Magnesium 
supplements are effective for mild-to-moderate depression and are an additional treatment option 
for patients suffering from depression.  
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Research has focused extensively on the negative health effects of inadequate 
magnesium (Mg) intake, but the extent of the problem of deficiency deserves further 
exploration. The notion that U.S. adults consume an inadequate amount of magnesium, 
leading to increased risk for chronic diseases, is plausible. Large, cross-sectional, 
population-based data sets indicate over half the adult population does not consume 
adequate amounts of magnesium. Changes in agricultural processes that reduce 
magnesium levels in crops combined with the increasing consumption of processed foods 
containing little to no magnesium have led to a decrease in mean daily intake over the 
past century. However, recent population-based studies show a steady and consistent 
recovery in magnesium consumption over the last several decades. A simple, rapid, 
accurate test for whole body Mg status is lacking and, although population-based studies 
have limitations, continued monitoring of Mg consumption is essential to determine 
whether this positive trend continues. In the meantime, since the health consequences of 
inadequate magnesium are well established, there are no reported cases of 
hypermagnesemia from food alone, and magnesium is found in healthy foods adults 






 The effect of inadequate magnesium (Mg) intake on health is well established 
and includes electrolyte, neuromuscular, neurologic, and cardiovascular abnormalities.
1-4
 
Adequate intake of Mg is essential due to the mineral’s role in energy production, 
prevention of dysrhythmias, blood pressure regulation, insulin resistance, and bone 
homeostasis.
2,5,6
 A simple, rapid, accurate test for whole body Mg status is lacking and, 
as a result, monitoring Mg status in U.S. adults is difficult,
7
 butMg consumption has 
reportedly decreased over the past century by 200-300 mg per day.
8-10
 The possible 
reasons for this decrease are multifaceted and include changes in agricultural processes 
and food consumption patterns. Mg homeostasis in humans is influenced not only by 
dietary intake but also by absorption in the gastrointestinal (GI) tract and excretion by the 
kidneys.
11
 However, further research is needed to draw any conclusions as to the extent 
of these factors on net Mg levels. If population-based studies, which use 24-hour recall 
data to track intake over time, support the idea of an increasingly Mg deficient 
population, the negative health effects are a public health concern.
4,7
 The aim of this 
paper is to explore the factors impacting Mg consumption over time and the current 
adequacy of intake in U.S. adults.  
Magnesium Basics 
Mg, as the fourth most abundant mineral and second most abundant cation in the 
human body, has numerous essential roles.
12
 In addition to being a cofactor for over 300 
enzymes, it is essential for anaerobic and aerobic energy generation, glycolysis, 
4 
 
mitochondrial oxidative phosphorylation, regulating movement of potassium, and acts as 
nature’s physiological calcium channel blocker.13  Mg is an essential mineral that plays a 
role in the physiological function of the heart, brain, and skeletal muscles. The human 
body contains ~25 grams of Mg with 50-60% found in bone, which  is responsible for 
maintaining normal extracellular magnesium concentrations, while the rest is found 
mostly in skeletal muscle and soft tissue.
6
  The GI tract and kidneys are the organs 
primarily responsible for Mg homeostasis. When dietary intake of Mg is low the percent 
absorbed from the diet by the GI tract increases and the amount excreted by the kidneys 
decreases to replenish stores.
6
 After consumption, around 30% is absorbed by the 
intestine, 5% is eliminated in feces, approximately 30% is used to replenish stores in 
bone, muscle, and other parts of the body, 30% is excreted via urine, and small amounts 
are lost via sweat.
13
  
Assessing Magnesium Status 
Bone and muscle are the two main compartments for storage and, because they 
are not easily or painlessly accessible, an accurate test for whole body Mg status is 
lacking.
7
 Clinical lab tests for assessing Mg include total serum Mg concentration (SMC) 
and 24 hour urine excretion. Normal serum levels are 0.75-0.95 mmol/L (1.8-2.3mg/dl).
6
  
Only 1% of total body magnesium is present in extracellular fluids and only 0.3% is 
found in serum.
11
 While SMC is the most convenient and economical way to measure 
magnesium, it is not reflective of intracellular magnesium levels
14
 and does not reflect 
bone stores, which might be dangerously low as the body uses them to preserve serum 
levels.
6,15
 SMC can also be low while total body stores are adequate as when a person is 
5 
 
taking a drug that acutely increases excretion of Mg.
16
 Twenty-four hour urine excretion 
is readily available, but it is a better assessment of magnesium wasting by the kidneys 
and not necessarily a test to assess Mg status.
16
  Mg in urine most likely shows the 
current snapshot of intake and a single 24 hour urinary Mg is not adequate for assessing 
Mg status due to the rapidity of change in urinary Mg excretion in response to dietary 
intake.
7,15
   
Other potential tests of Mg status are not widely available. Serum concentration 
of ionized Mg, the biologically active form, may be the most reflective of current status.
7
 
However, very few clinical laboratories offer this service.
16
 A Mg retention test, which 
assesses the amount of Mg excreted in urine after a parentally administered load test, is 
probably the best assessment of Mg deficiency since intracellular levels are 
physiologically representative.
16
 But it is a more invasive technique, is usually limited to 
use in research studies, and it is only appropriate for adults with adequate kidney and 
intestinal function.
6,17
 Also of interest, but requiring additional research, are phosphorous 
nuclear magnetic resonance (NMR) spectroscopy to measure brain magnesium and total 




The response by the body to ensure Mg homeostasis makes it difficult to 
determine daily requirements.
19
 The estimated average requirements (EAR) and 
recommended daily allowances (RDA) for Mg intake are based on age and gender (Table 
1.1). Current reference values stems from the fact that they were determined by 
measuring SMC in healthy normal individuals during data collection for National Health 
6 
 
and Nutrition Examination Survey I (NHANES I) in 1974.
20
 Between 1971 and 1974, the 
average serum Mg level in U.S. adults was 0.85 mm/L.
20
 In this same population a serum 
Mg deficiency of 21% in women and 1.5% in men was reported.
7,20
 Since then there have 
been changes in the food supply and prevalence of diseases such as diabetes that affect 
Mg status, which may indicate a need to reevaluate daily requirements.
7
 Reviews of the 
adequacy of the EAR question its validity.
4,7,15,21
 Population studies over the past few 
decades assessing both food and supplement sources of Mg indicate a majority of U.S. 
adults consume amounts below the EAR (Table 1.2).
22-25
 In fact, Mg was listed as a 
shortfall nutrient in the 2015 Dietary Guidelines, which indicates Mg status in the U.S. is 
a public health concern.
26
 Women consume less Mg than men and black males and 
females consume less than their white counterparts, a trend that is well documented going 
back to the 1970s.
20
  
Clinical Significance of Deficiency 
The clinical consequences of inadequate Mg status have been reviewed 
extensively.
1-4
 Hypomagnesaemia is associated with electrolyte, neuromuscular, 
neurologic, and cardiovascular abnormalities.
27
  Mg plays a role in myocardial energy 
production, prevention of dysrhythmias, and promoting vasodilation.
5
 Increased 
consumption of Mg can aid in treatment of CVD and prevention of sudden cardiac 
death.
2,4
 Correcting Mg status can help control blood pressure and reduce risk factors for 
CVD, especially in those with hypertension and those that are depleted in Mg due to 
diuretic use or poor dietary intake.
2
 Mg intake and serum Mg concentration are inversely 
proportional with c-reactive protein (CRP) levels.
4
 CRP, a measure of inflammation, is 
7 
 
associated with risk of cardiovascular disease (CVD), metabolic syndrome, and diabetes.
4
 
This relationship with inflammation may help explain why inadequate intake and 
hypomagnesaemia are associated with CVD, arrhythmias, heart failure, diabetes, and 
metabolic syndrome.
2,28-31
 Elevated risk of diseases even with SMC at higher levels than 
the present clinical cut off for deficiency further raise the question of the adequacy of the 
reference intervals.
7
 Latent, or subclinical, deficiency is likely associated with risk of 




The varied roles of Mg in the body have led to research on its impact on other 
chronic health conditions as well. The association between magnesium intake and 
depression is well documented.
23,33,34
 Magnesium plays a role in many of the pathways 
involved in the pathophysiology of depression and is found in several enzymes, 
hormones, and neurotransmitters and depression is also associated with inflammation.
35,36
 
Recent randomized clinical trials have found supplementation with magnesium improves 
symptoms of depression in patient with hypomagnesaemia
37
 and regardless of baseline 
Mg status.
38
 Mg is involved in bone cell growth and inadequate intakes can lead to 
decreased bone formation and loss of bone mass. Animal studies have shown that Mg 
levels at 10%, 25% and 50% of adequate intake lead to bone loss, decreased osteoblast 
and increased osteoclast activity.
4
 Adults suffering from migraines tend to be deficient in 
Mg and Mg’s role as a smooth muscle relaxant may also make ensuring adequate status a 
priority for alleviating symptoms of asthma.
5
 Recommendations for Mg supplementation 
8 
 
to alleviate symptoms of these clinical consequences of deficiency are currently under 
investigation.  
Hypermagnesaemia, on the other hand, is not a concern. Overconsumption of Mg 
from food intake alone has never been documented and rarely occurs from intakes from 




The negative health effects of inadequate Mg intake are not controversial, but the 
extent of the problem of deficiency deserves further exploration. The clinical significance 
of Mg deficiency in a majority of the U.S. is not inconsequential. A reliable and 
convenient clinical test for Mg status is not available to document changes in Mg status 
over time. Researchers rely on results from population-based studies to study changes in 
daily consumption throughout the past century. Daily intake has decreased from 400-500 
mg per day in the early 20
th





Mg intake is directly related to calorie intake but is influenced by the amount of Mg 
absorbed by the plant from the soil. Low Mg status may be an indicator of other 
suboptimal dietary and lifestyle patterns, such as inadequate intake of whole grains, 
fruits, and vegetables.
7
 Unhealthy dietary patterns are often influenced by socioeconomic 
status.
39
  Figure 1.1 illustrates the factors influencing Mg homeostasis. The following 
sections focus on factors impacting Mg consumption over the past century (Table 1.3). If 
the majority of the U.S. adult population is Mg deficient, the reasons for decreased 




Magnesium in Soil and Crops 
A decrease of Mg in the food supply is likely a major contributor to inadequate 
consumption of Mg and perhaps chronic latent deficiency.
7
 The mineral content of food 
differs according to the mineral content of the soil they are grown in, how the plant is 
grown and harvested, and the amount of processing prior to consumption. Wild plant 
foods consumed by hunter gatherers generally maintained higher micronutrient 
concentrations than do their domesticated counterparts.
40
 Historical data of soil fertility 
indicate changes in concentrations of minerals in products from the 1940s to the end of 
the 20
th
 century. Some studies report median declines of 5-40% or more of minerals in 
fruits and vegetables over the past 50 to 70 years.
13,41
 Magnesium concentrations in 
cheese have decreased by 20% and meat  by 15% due to decreased Mg in the feed given 
to animals.
42
 The exact change is difficult to quantify due to the methods of purchasing, 
pretreating, and analyzing the food items by different researchers.
43
 None the less, 
changes in the amount of Mg in the soil are reflected in crops. To increase the amount of 
Mg in food, there needs to be more Mg available in the soil.  
The reason for the change in the amount of Mg in crops is hypothesized to stem 
from changes in agricultural processes that result in soil induced dilution effect and 
genetic dilution effect.
41,42
 Soil dilution occurs as the result of environmental changes 
such as fertilization and irrigation, which tend to decrease concentrations of minerals in 
plants.
41
 Phosphorus from fertilizers can be beneficial to Mg concentrations in the plant at 
low doses, but detrimental at very high rates of application.
42
 Genetic dilution occurs 
when plant yield increases as a result of selective breeding.
42
 This process came about 
10 
 
during the “green revolution” in the 1960s and 1970s, which encouraged increased yield 
of grains and other crops by 2 to 3 fold in developing countries.
41,44
 For example, in 
fruits, vegetables, and grains approximately 80% to 90% of the dry weight yield is 
carbohydrate. When breeders select for a high yield they are selecting for high 
carbohydrate yield, with no assurance that any other nutrients are increasing in the same 
proportion.
41
 Mg content in the food supply is affected by these agricultural processes. 
Twentieth century wheat can contain almost 30% less Mg.
44
 Increasing grain yields over 
the past 40 years have provided additional food for the human population, but with a 
corresponding decrease in the availability of essential nutrients. 
In addition to the amount of Mg available to the plant from the soil, factors related 
to the presence of other nutrients and the growth of the plant affect the Mg content of 
crops.  The amount of Mg is influenced by competition with other ions (such as calcium), 
elevated concentrations of aluminum (which decreases Mg uptake
45
), and other factors 
that restrict the size of the root system.
42
 Mg is found in high concentrations in the 
chlorophyll of plants,
2
  but the developing layer of the plant actually becomes a barrier to 
absorption and less Mg is absorbed as the plant grows.
42
 The edible portion of a plant can 
also determine Mg intake. Root crops store 25-33% of their Mg content in the tap root, 
which is usually not consumed.
42
 Up to 50% of Mg is stored in the reproductive organs of 
plants such as seed or grain and are removed during processing.
42
 
Magnesium in Water 
Hard water is frequently considered an important source of Mg
42
 and can account 
for up to 10% of daily intake.
2
 The amount of Mg consumed from water varies greatly 
11 
 
depending on the mineral content of the water supply.
1,5
 Soft water has decreased 
concentrations of dissolved Mg due to the process of distillation.
7
 To meet the growing 
need for potable water, desalination has increased and the Mg content of desalinated 
water is less (0.8mg/L) than hard water (20-30 mg/L).
46
 Geography also plays a role in 
the amount of Mg in the water supply. North American bottled and tap water contains 
much lower levels of Mg than European counterparts.
47
 Levels of Mg in water differ 
significantly between states and even within areas of the same city.
47
 Tap water accounts 
for two thirds of water consumed at home, but only half of water consumed away from 
home.
48
 Per capita consumption of bottled water in the U.S. has increased from just under 
2 gallons in 1976 to over 36 gallons in 2015, an increase of about 6% per year.
49,50
 
Filtered and bottled water contain less Mg than tap water, although, again, amounts vary 




Changes in Food Patterns 
There are no excellent sources (providing 40% or more of the RDA per serving) 
or good sources (providing 25% or more of the RDA per serving) of Mg.
51
 The highest 
levels of Mg are found in green vegetables, beans, peas, legumes, nuts, and whole 
unrefined grains. Meat, fish, dairy, and fat contain little Mg.
52
 The amount of Mg in the 
U.S. food supply changed from 408 mg in the early 1900s to 349 mg in 1980, a 14% 
decrease.
53
 Increased intake of processed grains and potatoes paired with increases in 
dairy, meat, poultry, and fish is thought to be a major reason for the decrease. From 1909-
12 
 
1913 to 1980 the supply of protein from vegetables decreased by 33% while protein from 
animals increased by 24%, leading to a net reduction in Mg supply.
53
  
With 72% of total energy in the current Western style diet coming from dairy 
products, cereals, refined vegetable oils, and alcohol, it is a poor source of Mg and often 
contains only 30-50% of the RDA for Mg.
2,54
  Mg intake is directly related to calorie 
intake except when energy comes from high amounts of alcohol or refined sugars and 
oils.
1
 As a result, eating a typical American diet has to include higher amounts of calories 
or include supplements to meet Mg recommendations.
55
 Diets containing at least 3000 
calories per day may be needed, in such cases, to achieve adequate intake of Mg from 
diet alone, which exceeds the calorie needs of the average adult.
56
  
Sugar plus refined oil makes up over 36% of the U.S. diet.
40
 Adults in the U.S. 
consume a large proportion of total energy from energy-dense, refined sugars such as 
cakes, cookies, pies, sodas and soft drinks and consuming large amounts of these foods 
reduces the total vitamin and mineral density of the diet.
57
 Between 1909-1913 and 1980 
use of sugars and other sweeteners increased by 50%, 
53
 and continued to climb. Per 
capita consumption of refined sugars in the U.S. increased from 55.5kg in 1970 to 69.1kg 
in 2000.
40
 More recently, mean daily intake has decreased slightly from 21 teaspoons per 
day in 2003-2004 to just over 18 teaspoons in 2011-2012.
58
 From 1909-1999 per capita 
consumption of vegetable oil increased by 130%, shortening increased by 136%, and 
margarine increased by 410%.
40
 Changes in animal husbandry practices and decreased 
consumption of wild animals over the past two centuries led to the large scale addition of 
refined oils to the food supply.
40
 Fat storage depots of wild animals are mostly saturated 
13 
 
fatty acids, while muscle and organ tissues supply mostly poly and mono unsaturated 
fats. Year round dietary intakes of high amounts of saturated fat are not possible when 
relying on wild animals for meat, due to the seasonal cyclic depletion of saturated fat. 
Animal husbandry has made it feasible to prevent this seasonal decline in body fat and to 
also slaughter at peak body fat percentage. The discovery of processing procedures that 
allow for the storage of products with high concentrations of animal saturated fats 
(cheese, butter, tallow, salted fatty meats) allows for year round consumption of these 
high fat products.
40
   
Vegetables contain a high amount of Mg, but are consistently under consumed in 
the American diet. Use of processed vegetables increased 4 fold during the 20
th
 century, 
while consumption of fresh vegetables increased only during the first half of the 
century.
53
 Processing and boiling of vegetables leads to the loss of 80-90% of Mg and 
when these foods are the base of a person’s diet, deficiency can occur.1,13 From 1976-
1980 (NHANES II) to 1988-1994 (NHANES III) the percent of adults consuming three 
or more servings of vegetables per day increased from 27% to 35%.
59,60
 NHANES data 
from 1999-2002 indicate a small, but significant (P=0.03) decrease in mean daily intake 
with only 33% of adults consuming at least 3 servings of vegetables per day.
60
 Other 
population-based studies confirm that vegetable intake stalled and then decreased in the 
late 1990s. Behavioral Risk Factor Surveillance System (BRFSS) data from 1990 to 1994 
is consistent with the NHANES data from the early 1990s and indicates the percentage of 
U.S. adults meeting the guidelines for 5 servings of fruits and vegetables per day 





BRFSS data from 1994 to 2005 show an overall significant decrease in frequency of daily 
consumption of vegetables by U.S. adults from 2.03 times per day to 1.91 times (95% 
confidence interval -1.12, -0.10; P<0.001).
62
 More recent data from BRFSS indicate the 
intake of vegetables remains poor. From 2007 to 2010, 13% of the adult population met 
the recommendations for daily vegetable intake of at least 1.5 cups per day and in 2013 
the percentage decreased to 9%.
63
  
Adults following a vegetarian diet tend to have higher intake of Mg from food.
8
 
Varying degrees of vegetarianism (i.e. lacto-ovo, or pesco-vegetarian) result in higher Mg 
consumption compared to a typical Western diet. In comparison to a typical U.S. diet 
pattern, a strict vegetarian diet significantly increases the amount of Mg consumed (mean 
intake of 509 mg per day vs. 652 mg per day; P<0.05).
64
 The reason for the higher Mg 
intake is most likely a result of higher intakes of vegetables and legumes.
65
 The percent 




Breakfast consumption was associated with a predicted increase in daily fruit and 
vegetable servings in a rural U.S. population (coefficient 0.255; P<0.001).
67
 Mg intake is 
lowest and prevalence of inadequacy is highest in people not consuming breakfast and 
adequate intake is highest in those consuming ready to eat cereals (RTEC).
68
  The 
adequacy seen with consumption of breakfast is thought to be a result of the inclusion of 
whole grains and dairy products. Although dairy is not a rich source of Mg, it is 
consumed so frequently that is acts as a significant source of Mg in U.S. diets. Dairy and 
dairy products provided 18% of daily Mg in the National Food Consumption Survey 
15 
 
(NFCS) of 1977-1978 and over 10% of adults’ daily Mg in the Continuing Survey of 
Food by Individuals (CSFI) (1989-1991).
69,70
 While still a large part of the Western diet, 
dairy intake has decreased over time. Between 2001 and 2004, 15% of Americans 
consumed the recommended daily servings of dairy, but in 2007-2010 only 11% met the 
recommendation.
71
 Changes in the diet to meet the recommended servings predict a 
decrease of inadequate Mg intake in U.S. adults from 56% to 33%. The benefits were 
especially seen in older adults.
71
  
However, conflicting research has shown that if RTEC and milk products are 
consumed more than fruit, vegetables, lean meat, and seafood, the overall micronutrient 
density in the diet is lowered.
40
 The introduction of dairy and cereal grains as staples may 
have caused the average micronutrient content of the human diet to decline. The decline 
was worsened by milling techniques. In the latter part of the 19
th
 century, nutritional 
characteristics of milled grain changed due to the germ and bran being removed during 
the milling process.
40
 Only 16-18% of original Mg in many RTEC remains in the refined 
product.
18
 Diets high in processed carbohydrates result in a significantly lower intake of 
Mg.
72
 For example, a potato without the skin contains a third less Mg than one with skin. 
42
 White bread and cooked white rice contain almost a third less Mg than their whole 
grain counterparts.
52
 From 2003-2004 to 2011-2012, a small but significant increase in 
the consumption of whole grains was seen in the U.S. population (0.6 g to 0.9 g 
equivalent per day; P<0.01). Nevertheless, consumption is still far below the 
recommendation to consume 50% of grains as whole.
58
 These counter points regarding 
16 
 
dairy and RTEC intake reinforce the need to promote a balanced diet of various whole 
foods to attain nutritional adequacy. 





 Between 2009 and 2010 40% of U.S. adults consumed nuts 
on a given day, but only 6% of the U.S. population consumes tree nuts regularly.
73
 Tree 
nuts, similarly to dairy, are a great source of shortfall nutrients. Ninety-two percent of 
people eating tree nuts consume the EAR for Mg, compared to 40% of non-consumers 
and tree nut consumers exhibit a diet pattern of higher quality and nutrient adequacy 
overall.
54
 Between 2005 and 2012 daily consumption of nuts and seeds has increased 
slightly (0.60 ounce equivalents to 0.70 ounce equivalents) as has the intake of legumes 
(0.09 cups to 0.12 cups).
74
 While changes in consumption of these food items are not a 
reason for an overall decline in adequate Mg intake, they offer the potential for 
improving nutrient adequacy in the U.S. diet.  
Magnesium Supplements 
Supplements can be a major contributor to overall vitamin and mineral intake. In 
1986, 15% of the population was taking an over the counter Mg supplement. The most 
common amount was 100 mg, although daily intake and the form of Mg was not 
confirmed.
6
 A review of Mg supplement intake in the following decades using NHANES 
data shows that as of 2011-2012 Mg supplement use has increased to 28% of the 
population, although this is down from a high of 37% in 2005-2006.
75
 Use is consistently 
higher in females
6,75
 and increases with age.
76
 People using supplements tend to consume 
healthier diets and have higher intakes of Mg from food as well.
48,76
 Older adults taking 
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supplements are three times as likely to have adequate intake and older adults consuming 




Individuals with a higher socioeconomic status (SES) consume healthier diets.
77
 
Higher income and education are associated with higher consumption of reduced or 
nonfat milk, lean meats, whole grains, and with consuming at least five servings of fruits 
and vegetables per day, while low SES is associated with higher consumption of refined 
grains and added fats.
39,60,77
 Low educational status is associated with low earning 
potential, low purchasing power, and food insecurity.
39
 The prevalence of food insecurity 




 Food costs are a 
barrier to consumption of nutrient dense foods in low SES groups.
77
 Food insecure adults 
consume vegetables fewer times per month than food secure adults (69 vs. 76; P<0.05).
78
 
The need to maximize calorie intake and minimize food waste leads to not only the 
consumption of highly processed, shelf stable foods but also minimal variety.
77
 The price 
of fruits and vegetables has increased more than foods high in sugar and fat in the past 20 
years.
77,78
 The increase in price affects those living in poverty to a greater extent and 
decreases access to healthy food. The disparity between SES and fruit and vegetable 
intake has increased over time. Results from the 5 A Day for Better Health Program 
indicate that though awareness of the program encouraging consumption of fruits and 
vegetable in the 1990s increased, intake declined in non-white racial and ethnic groups.
79
 
This finding may help explain the change in vegetable intake at the end of the 20
th
 





Higher SES groups tend to consume higher amounts of most vitamins, minerals, 
and fiber regardless of overall energy intake.
77,80
 NFCS from the 1970s through the 1990s 
indicate individuals living in poverty consume less Mg.
69
 Gender, race, age, income and 
education level are associated with Mg intake as well as poverty level.
24,25,80,81
  NHANES 
III (1988-1994) data indicate older adults experiencing food insecurity consume only 
58% of the RDA for Mg while their food secure counterparts consume 77% of the RDA 
(P<0.05).
78
 Older adults in the U.S. with higher income meet the EAR for Mg to a 
significantly higher extent than those with low income (39% vs. 22%; P<0.05) due to a 
healthier overall diet pattern.
39
 NHANES 2011-2012 data indicate that the prevalence of 
U.S. adults meeting the EAR is greater for those with the highest income (~72%) versus 
those living in poverty (~50%; P<0.001) and those living in poverty are also less likely to 
take any dietary supplement (63% of those with higher income vs. 52% in the lowest 
poverty group; P<0.001) .
82
 Although it is important to note that over half of adults in the 
high-income group still consume less than the EAR, and many well-educated, healthy 
adults also consume inadequate amounts of Mg.
83
  
Mean changes in Mg intake over time 
The data to this point supports the idea of a population with less access to and less 
consumption of Mg compared to the previous century. However, when comparing the 
NFCS from 1977-1978 and the NHANES from 2013-2014, mean Mg intake in men 20 
years and older increased from 283 mg per day to 345 mg per day and in women of the 
same age from 204 mg per day to 268 mg per day (Figure 1.2; Joseph Goldman, MA, 
Food Surveys Research Group Agricultural Research Service, United States Department 
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of Agriculture, email communication, April 18, 2017). The data is consistent with the 
research indicating mean consumption in U.S adults is 200-300 mg per day, a decrease 
from a mean of 400-500 mg per day a century ago.
8-10
 Yet, despite evidence to the 
contrary, Figure 1.2 indicates overall Mg intake in U.S. adults is recovering. These 
surveys confirm women consume less Mg than men and indicate older adults and females 
aged 20-29 years still do not currently meet the EAR, but mean intake in these age groups 
continues to increase along with the rest of the population.  
Evidence for Inadequate Mg Status 
The contradictory information gathered here does not resolve the question as to 
whether U.S. adults consume adequate amounts of Mg. According to several population-
based studies investigating Mg intake in U.S. adults since the start of the 21
st
 century, a 
majority do not consume the EAR. There is population-based data reviewing changes in 
dietary patterns and other factors affecting Mg consumption to support this conclusion. 
U.S. adults are consuming more amounts of processed grains, oils, and sugar, animal 
sources of protein, relying on soft water and bottled water more often, and consuming 
fewer fruits and vegetables and Mg supplements. At the same time, according to 
agricultural research, the amount of Mg in food is decreasing as a result of changing crop 
management practices. Yet 24-hour recall data from population-based surveys indicate an 
overall increase in Mg intake in all adults with mean intake reaching the EAR as of 2014.  
Due to the limitations of consumption data from population-based studies, results 
should be interpreted with caution. Over the years, the way in which intake data is 
analyzed changes or differs by investigator and comparing results is difficult. Some 
20 
 
studies group foods according to conceptually and nutritionally similar characteristics, 
but do not disaggregate food mixtures.
84
 The result is potentially inflated values for some 
macro and micronutrients.
70
 Other studies separate food mixtures into individual 
ingredients and are then able to assess the nutrient contribution of each food, which 
results in a more accurate portrayal of percent distribution.
70
 Comparing studies using 
differing methods may result in flawed conclusions about changes in consumption over 
time. Methods of surveys themselves can make it difficult to compare data if they do not 
properly weigh the data to the national population and use methodology that considers 
the complex sample design.
85
 The 24-hour recall is the most common dietary data 
collection instrument used in surveillance and is the tool used in What We Eat in 
America (WWEIA), the dietary component of the NHANES.
86
 A limitation of the 24-
hour recall is that intake varies greatly from day to day and is not indicative of long term 
intake, although at the population level, it is thought to provide valid estimates of nutrient 
intake.
87
 Interviewer training and interviewer inter reliability is also a limitation of 24-
hour recalls. Decisions about the degree of probing for additional details for foods or 
recipes, as well as the use of default ingredients in recipes, impact the results. Trained 
interviewers are utilized for WWEIA and methods are validated.
88
  
The availability of reliable food composition databases to analyze 24-hour intake 
data, in addition to appropriate statistical modeling to calculate the distribution of usual 
intake in a population, is essential to producing accurate dietary recall data.
86
 There is 
evidence that the Mg in food has decreased over time due to agricultural processes. The 
amount of Mg reported in food varies with the seasons and can change frequently due to 
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manufacturer reformulations. Food composition data used to analyze intake must be 
continuously updated to reflect these changes. The United States Department of 
Agriculture (USDA) provides the food and nutrient databases used for population-based 
analyses. The National Database for Standard Reference (SR) is the main source of food 
composition data in the U.S.
89
 It is updated annually and data are derived from USDA 
contracted analyses, the food industry, and the scientific literature. The Food and Nutrient 
Database for Dietary Studies (FNDDS) provides nutrient values and weights for typical 
food portions and is the underlying database for analyzing 24 hour recalls from survey 
responders in WWEIA.
89
 There are no missing values in FNDDS and it is updated 
biennially. The nutrient values for the FNDDS are derived from SR. Food composition 
data are integral to the success of all federal dietary surveys by the USDA and 
Department of Health and Human Services. The ability of the agencies to keep pace with 
changes in the U.S. food system is commendable, but the databases are limited by the 
high cost of food analysis coupled with funding constraints.
90
  
The Nutrition Data Set for Research (NDSR) is a Windows-based program 
designed for the collection and analysis of 24-hour dietary recalls, food records, menus, 
and recipes. It combines data from the USDA, food manufacturers, and scientific 
literature and includes more individual products than the FNDDS.
90
 The database, 
developed and supported by the Nutrition Coordinating Center at the University of 
Minnesota, is used frequently in nutrition research. Due to the importance of knowing the 
nutrient content of food items, a recent study compared phosphorous values reported in 
NDSR for 46 products with results from a food analysis laboratory.
91
 The results 
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indicated 78% of the products had higher levels of phosphorous than the NDSR reference 
values. This small study investigated the potential effects of inaccuracies in the nutrient 
database on study results. While it involved only one nutrient, it points to the possible 
limitations of current nutrient databases used in research and the ability to use results to 
make decisions about the nutritional status of the population.  
Future Directions 
In early 2015, as a result of the Dietary Guidelines Advisory Committee listing 
Mg as a shortfall nutrient, a workshop convened in the U.S. to assess the evidence for the 
need to revise the serum magnesium reference level. The group concluded that adequate 
scientific data exists to warrant an increase in the reference level to improve clinical care 
and public health.
7
 To determine the reference level, a validated biomarker that most 
reflects Mg status is needed; whether it is a dietary, urinary, serum, or a combination 
marker is unknown. Other recommendations from the group include addressing methods 
of improving intake of Mg in crops and packaged foods, increasing public emphasis and 
education on the importance of Mg in the diet, and the development of systems to 
monitor Mg insufficiency.
7
 While the development of a validated biomarker is essential, 
it will not be achieved quickly. The other recommendations are either already being 
implemented as part of larger public health initiatives or could be relatively easily.  
Increasing the nutrient content of crops, minimizing loss during processing, and 
preserving nutrients during transport is possible. The amount of Mg that plant foods 
provide can be greatly improved by increasing the availability of Mg during growth and 
production.
92
 Mg applications to the soil take time to become incorporated into crops; 
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however, foliar sprays of Epsom salts can increase Mg content of plants within 6 weeks.
93
 
Agronomic practices that encourage supplying adequate nutrients to the plant during 
vegetation, increasing the percent of edible plant parts, and use of high efficiency 
fertilizer along with low leaching techniques are additional suggested techniques for 
increasing Mg in food.
42
 The quality and nutrient content of fruits and vegetables is also 
determined by the characteristics of the supply chain (time since harvest and type of 
processing).
94
 Preservation methods can reduce the nutritional losses and increase shelf 
life, minimizing the impact of “food miles”.94  
Consuming a variety of foods high in Mg should be encouraged in all adults, 
regardless of the presence of lifestyle factors or chronic diseases that increase the risk of 
deficiency.  Eating more whole grains, vegetables, legumes, nuts, and seeds can lead to 
higher intakes of Mg and other short fall nutrients. Decreased reliance on refined sugar 
and oils also decreases the risk of Mg deficiency. Modeling of various dietary scenarios 
indicate increasing plant foods by 100% of current intake and eliminating animal 
products decreases the percentage of people with inadequate Mg intake by 5-8%.
95
 
Increasing dairy products by 100% without changing the amount of intake from plant 
foods decreases the rate of inadequate Mg by 12%, but this model also increases calorie 
intake by almost 200 calories per day in.
95
 An increase in total calorie intake with 
increased dairy intake would need to be counterbalanced with other dietary or lifestyle 
changes. The total amount of calcium consumption should be taken into account when 






Increasing the Mg concentration in the plant, and thus how much is consumed, 
might be more feasible than changing eating patterns since evidence that simply 
increasing awareness and knowledge of good nutrition practices leads to long term 
behavior change is lacking.
96
 Education level can affect not only purchasing power but 
also exposure and understanding of dietary information and healthy behavior messages.
80
 
Strategies to encourage healthy eating patterns must be continually evaluated and revised 
to stay current with changes in the market and consumer needs. Due to the lower intake 
of Mg in minority groups, future programs hoping to improve diet patterns, and thus 
increase Mg intake, should focus not only on awareness around the benefits of increasing 




Not addressed by the working group is the use of supplements to fill the gap 
between food intake and the RDA. There have been no reported cases of 
hypermagnesemia from food alone, even in people with inadequate kidney function, and 
toxicity from supplements is rare.
6
 Supplements can play a large role in meeting Mg 
needs.
83
 Adults whose diet or medical history put them at higher risk for deficiency may 
benefit from Mg supplements in a highly absorbable forms, such as Mg salts. Generally 
tolerated in doses below the upper tolerable limit of 350 mg per day in those with 
adequate kidney function, higher doses can cause GI upset.
6
 GI upset acts as a limiting 
factor in the amount of Mg that is consumed and leads to decreased intake or termination 
of consumption prior to reaching toxicity levels. Changes in SMC occur within weeks of 





A diagnosis of hypomagnesaemia due to inadequate dietary intake alone is rare.
1
 
As discussed, this may partly be due to the body’s ability to utilize stores and maintain 
adequate SMC in times of deficiency. Several factors increase the requirement for Mg 
due to decreased absorption or increased excretion. However, many of the causes are not 
well understood or are not easily modifiable. Compounds in food such as phytic acid, 
oxalic acid, and protein, chronic conditions such as diabetes and gastrointestinal 
disorders, and behaviors such as smoking and alcohol consumption, as well as aging and 
medications may impact Mg absorption and excretion.
6,43,99-102
 More research to 
determine the overall effect of these factors on net Mg levels is needed. Increasing Mg 
consumption through changes in agricultural processes and consumption of whole foods 
is likely a more realistic approach to ensuring adequate Mg status in U.S. adults at this 
time.  
Conclusion 
Until a valid biomarker for Mg status is discovered, continued monitoring of Mg 
intake via future population-based studies is essential. Despite the potential for deceased 
Mg intake as a result of changes in agricultural practices and dietary patterns, mean Mg 
intake in U.S. adults has improved over the past 40 years. However, positive dietary 
trends can stall and then decline and continued monitoring is essential. In the meantime, 
since there are no reported cases of hypermagnesemia from food alone, the health 
consequences of inadequate Mg are well established, and Mg is found in healthy foods 
adults should consume more often, there are few reasons not to encourage increased Mg 
intake from food. A public health campaign directed solely at Mg consumption in 
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addition to those to increase fruit, vegetable, and whole grain consumption is most likely 


















Table 1.1 United States published requirements for magnesium
6
 
Age Male Female Pregnancy Lactation 
Estimated Average Requirement 
19-30 years 330 255 290 255 
31-50 years 350 265 300 265 
51-70 years 350 265 
 
  
>70 years 350 265 
 
  
Recommended Dietary Allowance 
19-30 years 400 310 350 310 
31-50 years 420 320 360 320 
























Moshfegh, et al. (2005)
81
 2001-2002 food  19+   
      Male 
   
64% 
      Female     
 
67% 
Moshfegh, et al. (2009)
25
 2005-2006 food  19+ 
       Male       53% 
      Female 
   
56% 




supplements 20+ 54% 





    White       43% 
      Male 
   
44% 
      Female       41% 
   Black 
   
69% 
      Male       69% 
      Female 
   
69% 
Cifelli, et al. (2016)
94
 2007-2010 food 19+ 56% 
Abbreviations: NHANES, National Health and Nutrition Examination Survey; EAR, 













































































Table 1.3 Dietary factors negatively influencing consumption of magnesium: 
20th to 21st century 
Decreased 
• Magnesium in soil 
• Magnesium in crops 
• Consumption of plant based diets 
• Consumption of dairy products 
 Increased 
• Consumption of soft water and bottled water 
• Reliance on animal protein 
• Use of refined sugar and oils 
• Consumption of processed grains and vegetables 
31 
 






































 SOURCE: Joseph Goldman, MA, Food Surveys Research Group Agricultural Research 
Service, United States Department of Agriculture, email communication, April 18, 2017. 
All estimates from first day of intake collection which was collected in person. All 
statistics weighted to represent the national population using methodology that 
considered the complex sample design. 
b
National Food Consumption Survey 1977-1978; Continuing Survey of Food Intakes by 
Individuals 1989-1991, 1994-1996; What We Eat in America, National Health and 
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Background: Depression is a common and often disabling disorder. Magnesium 
supplementation has been linked to improvement in depressive symptoms but consensus 
on the relationship between magnesium and depression has not been reached.  
Methods: The purpose of this study was to test the existence of an association between 
dietary magnesium intake and depression in the adult U.S. population. A cross-sectional, 
population-based data set (National Health and Nutrition Examination Survey) was used 
to explore the relationship of magnesium intake and depression in 8,894 U.S. adults 
(mean age 46.1; 47.4% male) from 2007-2010. Using logistic regression to model the 
relationship between the presence of depression (Patient Health Questionnaire Score >5) 
and low magnesium intake (<184 mg/day), we examined the risk ratio (RR) of 
magnesium intake and its 95% confidence interval. 
Results: After adjustment for all potential confounders, the strength of association of 
very low magnesium intake with depression was statistically significant (RR=1.16; 
95%CI 1.06, 1.30; P=0.026). Adjusting for all other covariates, low magnesium intake 
was associated with depression in subjects under age 65 (RR 1.22; 95%CI 1.06, 1.40; 
P=0.007), but appeared protective in seniors (RR 0.75; 95%CI 0.56, 0.98; P=0.032). 
Conclusions:  We found a significant association between very low magnesium intake 
and depression, especially in younger adults. The finding of the potential protective effect 






Depression is a common and disabling disorder. Almost 11% of adults older 
than 60 and 18.8% in those younger than 60 suffer from depression.
1
 Although both 
pharmacologic and behavioral therapies are effective for many patients, they have 
important limitations. Medications can take weeks to have an effect, often have 
significant adverse effects, and fail to help many patients at all.
2
 Non-pharmacologic 
approaches such as Cognitive Behavioral Therapy are also effective
3
, but require highly 
trained therapists and weeks to achieve effectiveness. 
As a result of the need for additional treatment options, interest in the role of 
nutrition in modulating depressive symptoms has grown. Magnesium plays a role in 
many of the pathways involved in the pathophysiology of depression and is found in 
several enzymes, hormones, and neurotransmitters.
4
 Depression and magnesium are both 
associated with systemic inflammation.
5, 6
 National data indicate a significant portion of 
the population has magnesium intake below the Estimated Average Requirement (EAR).
7
  







 and chronic fatigue 
syndrome.
10
 Low magnesium status has been associated with increased depressive 
symptoms in several different age groups and ethnic populations.
11-14
  
 Issues in study design have led to inconclusive results and skepticism of 
magnesium’s role in depression. Serum magnesium levels were used to indicate 
magnesium status in some studies,
11, 15
 but its reliability is questionable.
16, 17
 Clinical 
trials have suffered from limited sample sizes,
10, 11





 which is poorly absorbed,
17
 and restrictive inclusion criteria.
11
 With varying 
outcomes, different populations and age ranges, and limited sample sizes, consensus on 
the relationship between magnesium intake and depression has not been reached.  
Some cross-sectional studies have reported an inverse relationship between 
magnesium intake and standardized depression scores in populations with low 
magnesium intake.
12-14, 19
 Because these studies were conducted outside of the United 
States, their results should be validated in the U.S. population. One longitudinal study
20
 
did not find an inverse relationship, although it was underpowered to detect a significant 
reduction in depression.  
If proven effective, increased magnesium consumption through diet or 
supplementation might address some of the limitations of currently available treatment. 
Magnesium is found in many common foods and emphasis on these foods can easily 
affect magnesium status. Although it can lead to hypermagnesemia and diarrhea, 
magnesium supplementation is, in general, a safe treatment with few unanticipated side 
effects. Magnesium supplementation provides very quick results. Case studies of 
magnesium supplementation reported improvements in depression, anxiety, and sleep 
within one week.
8, 11
 Therefore, we sought to test the existence of a relationship between 
dietary magnesium intake and depression using a large, cross-sectional, population-based 
data set from the U.S. 
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Subjects and Methods 
Data Source and Subjects 
To investigate the question of whether there is an association between 
depression and magnesium intake, we conducted a cross-sectional study using the 
National Health and Nutritional Examination Survey (NHANES). NHANES participants 
undergo extensive interviews and laboratory assessments including measures of dietary 
intake, dietary supplements, socioeconomic factors, clinical characteristics, and personal 
habits.
21
 By applying the weighting scheme supplied by the Centers for Disease Control 
and Prevention, NHANES can be used to represent the sex-, age-, race- and ethnicity-
adjusted non-institutionalized population of the U.S. To increase the power of the 
analyses, we combined the data from two separate waves of the survey (2007-08, and 
2009-10).
22
 We included all subjects at least 20 years old with complete data for the 
outcome, predictor, and all the candidate confounders.  
Variables 
The main predictor variable was total magnesium intake in milligrams (mg)/day 
calculated from 24 hour dietary and supplement recall data. Intake was used because of 
the unreliability of serum magnesium levels
16
 and because it is directly modifiable and 
could serve as an intervention. Low magnesium intake was defined as intake in the 
lowest quintile (<184 mg/day). Magnesium deficiency is defined with age- and sex-
varying thresholds taken from the EAR as intake <350 mg/d for men over age 30, <330 





The  outcome variable was the Patient Health Questionnaire-9 (PHQ-9) score, a 
validated survey tool for measuring the presence and severity of depression in adults.
24
 
The PHQ-9 score is the sum of the responses to nine items representing symptoms of 
depression. Each is graded by the patient according to how often they have experienced 
the symptoms over the previous two weeks, from 0 (not at all) to 3 (nearly every day). 
PHQ-9 scores range from zero to 27 and were dichotomized into depressed (PHQ-9 score 
5-27) or not (PHQ-9 score 0-4).  
Based on review of the literature and our clinical experience, we considered age, 
sex, race, ethnicity, education, marital status, household income, food security, tobacco 
use, alcohol intake, diabetes, kidney disease, and folate intake as potential confounders of 
the relationship between depression and magnesium intake. Race and ethnicity were 
combined into a single dichotomous variable of non-Hispanic white vs. all others. 
Education was dichotomized as having a high school diploma (or equivalent) vs. not. 
Marital status was characterized as married or living as married vs. single, divorced, 
widowed or separated. Household income was dichotomized as low if it was reported to 
be $35,000 per year or less. Food insecurity was present if the subject endorsed any of the 
following three statements: “(I/we) worried whether (my/our) food would run out before 
(I/we) got money to buy more” or “The food that (I/we) bought just didn't last, and (I/we) 
didn't have money to get more” or “(I/we) couldn't afford to eat balanced meals.” 
Tobacco use was considered present if the patient endorsed current smoking vs. absent 
for former smokers and those who never smoked. Alcohol use was coded as the average 
number of units consumed per day over the past year. A unit of alcohol is one can of 
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beer, one glass of wine, or one ounce of liquor. Non-drinkers were coded zero. Diabetes 
and kidney disease were considered present if the patient endorsed that a doctor or other 
health professional had told them they had the diagnosis. Folate intake in (micrograms 
per day) included dietary folate equivalents of food plus supplements and was 
dichotomized at <230 µg/d (the lowest quintile of daily folate intake).  
Statistical Analysis 
The primary hypothesis was that depression is associated with magnesium 
intake while adjusting for possible confounders. We used unadjusted nonparametric 
Wilcoxon-type tests of trend to assess the relationships between quintiles of magnesium 
intake and other subject characteristics.
25
 We used logistic regression to model the 
relationship between the presence of depression (PHQ >5) and low magnesium intake 
(<184 mg/day, the lowest quintile) and tested the hypothesis by examining the odds ratio 
(OR) and relative risk (RR)
26
 on magnesium intake and its 95% confidence interval (CI). 
Each potential confounder was tested in a separate univariate logistic regression for 
association with the outcome (depression) and the main predictor (low magnesium 
intake). If the variable was associated with both outcome and predictor with each P<0.1, 
it was considered a potential confounder and included in the multivariate model. We 
explored the use of the magnesium as a function of energy (milligrams of 





 vary with age and gender, we constructed 
additional models including interaction terms to explore the possibility of interactions of 
magnesium with gender and magnesium with age. All analyses employed the 
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stratification and weighting scheme recommended for NHANES by the National Center 
for Health Statistics
22
 using Stata13.1 (College Station, TX). P values <0.05 were 
considered to be statistically significant. 
Results 
Of the adult subjects in the NHANES data set, 73% met eligibility criteria, for a 
final sample size of 8,894 (see Figure 2.1). The characteristics of the sample are 
described in Table 2.1. All the selected covariates showed significant trends across the 
quintiles of magnesium intake. Depression was most prevalent in the lowest quintile of 
magnesium intake.  
The univariate regression of low magnesium intake and depression 
demonstrated a strong statistically significant association with an OR of 1.73 (95%CI 
1.48, 2.02; P<0.001) and an RR of 1.49 (95%CI 1.35, 1.66; P<0.001) (Table 2.2). All the 
potential confounders were associated with both low magnesium and depression (P<0.1) 
and were retained in the multivariate model (except household income because it was 
highly correlated with food insecurity). After adjustment for all potential confounders, 
the strength of association of low magnesium intake with depression was attenuated but 
remained statistically significant with an OR=1.21 (95%CI 1.02, 1.42; P=0.026). This is 
equivalent to a RR of 1.16 (95%CI 1.06, 1.30; P=0.026). The use of magnesium as a 
function of energy gave similar results. 
Over half of the population (54%) reported deficient magnesium (intake less 
than the EAR). Deficiency was significantly associated with depression in the univariate 
model (OR 1.13; 95%CI 1.01, 1.27; RR 1.10; 95%CI 1.01, 1.20; P=0.04) but not in the 
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multivariate adjusted analyses (OR 0.97; 95%CI 0.85, 1.09; RR 0.98; 95%CI 0.88, 1.07; 
P=0.57). 
Only one of the covariates had a significant interaction with depression. Older 
age interacted significantly with low magnesium intake (OR 0.51; 95%CI 0.37, 0.72; 
P<0.001). Adjusting for all other covariates, low magnesium intake was associated with 
depression in subjects under age 65 (OR 1.31; 95%CI 1.08, 1.58; RR=1.22; 95%CI 1.06, 
1.40; P=0.007), but appeared protective in seniors (OR 0.69; 95%CI 0.49, 0.97; 
RR=0.75; 95%CI 0.56, 0.98; P=0.032) (Figure 2.2). 
Discussion 
Overall, we found a significant association between low magnesium intake and 
depression, especially in younger adults. The increased prevalence of depression was 
confined to the lowest levels of magnesium intake. Nonetheless, the effect is very strong, 
with a >50% higher rate of depression in the lowest quintile of intake compared to those 
consuming greater amounts. A very different pattern was observed in seniors (Figure 2.2 
and Table 2.3). First, the overall rates of depression were lower. Second, the spread in 
rates across the levels of magnesium intake were much higher for younger adults (23% to 
37%) than in seniors (15% to 21%). Third, the lowest quintile of intake among seniors 
did not have the highest prevalence of depression. Rather, the highest rates occurred in 
the group with the highest intake. Although the adjusted odds of depression were 
significantly greater in the highest intake group compared to the lowest quintile (Table 
2.3), there was no clear dose-response relationship, and the clinical significance of this 
finding is uncertain. The large sample size available for analysis (372 to 435 seniors in 
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each quintile of magnesium intake) may be responsible for making a small or even 
negligible effect appear statistically significant. Even if we discount the apparent adverse 
effect of high magnesium intake in seniors, there is little doubt that the increased 
prevalence of depression with low intakes seen in younger subjects is absent after age 65. 
By 2030, close to 20% of the population will be older than 65 (up from the current 
12.9%).
28
 Therefore, the number of people with late-life depression will also increase. 
Depression later in life increases risk for cardiovascular disease and mortality
29-31
 and 
depressive symptoms lasting more than one year are associated with a significant 
increased risk of mortality.
29
 Newly depressed older adults are at a higher risk for 
mortality and those with worsening depression have a 70% increase in mortality risk 
compared with patients with stable depression scores.
29
 Therefore, understanding 
modifiable risk factors for depression in the older population is particularly useful. 
Our data show over half of adults do not consume adequate amounts of 
magnesium. This finding is similar to other U.S. population studies.
7
  Magnesium 
excretion increases while absorption decreases with age
32
 because of various chronic 
diseases and decreased intake of foods high in magnesium. Compared with imipramine, 
magnesium supplementation was effective in treating depression in older adults with 
hypomagnesaemia and type 2 diabetes in a randomized control trial.
11
 The current 
analysis differs by suggesting a detrimental effect of higher magnesium intake in older 
adults. The differences may be because this is a study of a general U.S. population with 




Little is known about the mechanism of the possible effect of magnesium on 
depression. Even less is known about this mechanism in elderly and why the association 
might differ between age groups. The current findings might be due to unidentified 
confounders, reverse causality, or data error. The PHQ has been found to be comparable 
with the Geriatric Depression Screen in a convenience sample of elderly primary care 
patients.
33
 However, the existence of an emotional paradox in elders,
34
 in which older 
adults experience higher levels of well-being despite cognitive and physical decline, may 
influence how depression is identified and scaled in this group and make the PHQ less 
sensitive.  
Several studies have looked at whether overall dietary pattern is more important 
than specific nutrients when looking at nutrition’s influence on depression. Among adults 
with mood disorders, mineral intakes may be associated with psychiatric disorders more 
so than vitamin intakes.
35
 We cannot rule out that a specific dietary pattern or 
combination of nutrients would show a synergistic effect and a stronger relationship with 
depression than magnesium alone. For instance, residents of Greece, where most people 
follow the Mediterranean Diet Pattern, have a lower rate of depression and mental 
disorders.
36, 37
 Changing dietary patterns takes time, however, as well as commitment on 
the part of the patient. Emphasis on consumption of high magnesium foods such as green 
leafy vegetables, legumes, nuts, seeds and whole grains could offer a dietary approach to 
controlling symptoms of depression. Advocating for increased magnesium intake through 
food can lead to a healthier overall diet and might be attractive to patients that have 
previously experienced unwanted side effects from medications for depression. 
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Magnesium supplementation may be effective in as little as one week
8
 but may lead to 
stomach upset such as nausea, vomiting, or diarrhea in some people. However, toxic 
levels are unlikely to occur when it is given in the recommended dose and kidney 
function is normal.
16
 Whether increased dietary consumption of magnesium would lead 
to an improvement in symptoms just as quickly as supplements is unknown. 
Strengths and Limitations 
This study has several strengths. The sample size was large and representative of 
almost 180 million American adults. The analysis includes the most recent available data 
from 2007-2010 and captures both dietary and supplemental intake. Although the 
assessment of magnesium intake at only one time point may not reflect long term intake, 
trained interviewers were used to collect the data and the methods were validated and 
consistent over the four years of data collection.
38
 In addition to social, demographic, 
behavioral and clinical covariates, this analysis also controlled for folate intake, which 
has not been included in many previous analyses.  
As with all observational studies, we cannot exclude the possibility of additional 
confounding not accounted for by the analysis. Likewise, we cannot rule out reverse 
causality to explain the association between magnesium intake and depression. In other 
words, poor dietary intake of magnesium could be a result of mental illness.   
Conclusion 
This study enlarges upon previous research finding a relationship between 
magnesium intake and depression. Although very low magnesium intake appeared 
protective for depression in seniors, it was associated with higher rates of depression in 
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younger adults. Rigorous, randomized clinical trials, with adequate power to analyze 




Figure 2.1 Inclusion flow diagram 
 
 





2007-08              10,149 
2009-10              10,537 
 
Total   20,686 
Age <20 
N = 8,533 
Missing PHQ-9 
N = 911 
Missing magnesium intake data 
N = 971 
Missing 1 or more covariates 
N = 1,377 
Complete records 
analyzed 




Table 2.1 Subject characteristics by quintile of magnesium intake* 
Characteristic 
  Quintile   
Total 
1 2 3 4 5 
Sample size       
N 1,681 1,727 1,834 1,816 1,836 8,894 






















Depression (PHQ-9 score)       
Mean 
Range 



















Age        
Mean (y)  

















































Gender        
Male 26.9% 38.8% 46.2% 53.5% 63.2% 47.4% 
Social       
High school graduate 
Married (or living as married) 
Food insecurity  































Habits       
Current smoker 




























Dietary Folate Equivalent 
intake       
Lowest quintile (< 230 µg/d) 58.6% 23.2% 9.1% 3.4% 1.5% 16.5% 
*The trend across quintiles of magnesium intake is significant with P<0.001 for all 
characteristics using an unadjusted nonparametric test of trend.
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Table 2.2 Logistic regressions on depression 
Independent Variable Odds Ratio 95% CI P 
Univariate model    
Low magnesium 1.73 1.48, 2.02 <0.001 
Multivariate model    
Low magnesium 1.21 1.02, 1.42 0.026 
Male  0.61 0.53, 0.70 <0.001 
Age 65+ 0.65 0.54, 0.77 <0.001 
Non-Hispanic white 0.95 0.68, 1.32 0.75 
High school graduate 0.77 0.64, 0.93 0.007 
Married 0.70 0.61, 0.80 <0.001 
Drinker 1.06 0.99, 1.12 0.073 
Chronic Kidney Disease 2.50 1.66, 3.79 <0.001 
Smoker 1.78 1.52, 2.10 <0.001 
Diabetes 1.63 1.29, 2.06 <0.001 
Food insecurity 2.30 1.90, 2.78 <0.001 
Low folate intake 1.11 0.92, 1.35 0.28 































































































The prevalence estimates for each quintile of magnesium intake for each age group were 
adjusted for gender, race, ethnicity, education, marital status, alcohol intake, smoking, 
kidney disease, diabetes, food insecurity and low dietary folate. Quintiles of magnesium 
intake are labeled as milligrams per day. 
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Table 2.3 Adjusted odds of depression by age and magnesium intake* 
Magnesium Intake Odds Ratio 95% CI P 
Age < 65    
0-183 mg/day 1   
184-246 mg/day 0.81 0.67, 0.98 0.032 
247-315 mg/day 0.69 0.52, 0.92 0.012 
316-417 mg/day 0.76 0.63, 0.91 0.005 
418-2,437 mg/day 0.80 0.59, 1.09 0.15 
Age 65+    
0-183 mg/day 1   
184-246 mg/day 1.38 0.87, 2.18 0.17 
247-315 mg/day 1.29 0.79, 2.10 0.29 
316-417 mg/day 1.30 0.83, 2.03 0.24 
418-2,437 mg/day 2.15 1.34, 3.45 0.002 
*Odds ratios and confidence intervals (CIs) were adjusted for sex, race, ethnicity, 
education, marital status, alcohol intake, smoking, kidney disease, diabetes, food 
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Current treatment options for depression are limited by efficacy, cost, 
availability, side effects, and acceptability to patients. Several studies have looked at the 
association between magnesium and depression, yet its role in symptom management is 
unclear. The objective of this trial was to test whether supplementation with over-the-
counter magnesium chloride improves symptoms of depression. An open-label, blocked, 
randomized, cross-over trial was carried out in outpatient primary care clinics on 126 
adults (mean age 52; 38% male) diagnosed with and currently experiencing mild-to-
moderate symptoms with Patient Health Questionnaire-9 (PHQ-9) scores of 5-19. The 
intervention was 6 weeks of active treatment (248 mg of elemental magnesium per day) 
compared to 6 weeks of control (no treatment). Assessments of depression symptoms 
were completed at bi-weekly phone calls. The primary outcome was the net difference in 
the change in depression symptoms from baseline to the end of each treatment period. 
Secondary outcomes included changes in anxiety symptoms as well as adherence to the 
supplement regimen, appearance of adverse effects, and intention to use magnesium 
supplements in the future. Between June 2015 and May 2016, 112 participants provided 
analyzable data. Consumption of magnesium chloride for 6 weeks resulted in a clinically 
significant net improvement in PHQ-9 scores of -6.0 points (CI -7.9, -4.2; P<0.001) and 
net improvement in Generalized Anxiety Disorders-7 scores of -4.5 points (CI -6.6, -2.4; 
P<0.001). Average adherence was 83% by pill count. The supplements were well 
tolerated and 61% of participants reported they would use magnesium in the future. 
Similar effects were observed regardless of age, gender, baseline severity of depression, 
62 
 
baseline magnesium level, or use of antidepressant treatments. Effects were observed 
within two weeks. Magnesium is effective for mild-to-moderate depression in adults. It 




Depression affects 350 million people worldwide and is predicted to be the 
leading cause of disease burden by 2030, based on disability-adjusted-life-year [1]. Initial 
antidepressant trials of adequate dose and duration result in only about 50% of patients 
achieving remission [2]. Even after the addition of other treatments, 20% still suffer from 
symptoms after 2 years. Non-pharmacologic approaches such as Cognitive Behavioral 
Therapy and lifestyle interventions require highly trained therapists and several weeks to 
months to achieve effectiveness [3]. There is a great need for additional treatment 
options.  
The association between magnesium intake and depression is well documented 
[4-7]. Improvement in depression with magnesium supplementation has been reported 
inconsistently [8, 9], although few clinical trials exist. One trial found magnesium 
chloride to be effective for depression in seniors with type 2 diabetes [10] while another 
trial found magnesium citrate decreased depression in patients with fibromyalgia [11]. 
One negative trial used magnesium oxide [12], known to be poorly absorbed. 
The aim of this study was to test the hypothesis that 6 weeks of oral magnesium 
chloride (MgCl2) supplementation will improve symptoms of mild-to-moderate 






This was a 12-week open label randomized cross-over control trial. Participants 
were recruited through primary care providers (PCPs) within a single academic medical 
center and randomized to begin MgCl2 supplementation immediately or at week 7 
(delayed). During the other 6-week period, they took no MgCl2. Prior to the start of the 
study the Institutional Review Board of the University of Vermont approved the study. 
All subjects provided written informed consent. Trial registry can be found at 
clinicatrials.gov (Identifier: 02466087). 
Participants 
The target population was adults with mild-to-moderate depression. Inclusion 
criteria were: 1) 18 years of age or older; 2) no change in treatment plan for depression 
for the past 2 months and going forward (including no current treatment, stable use of 
antidepressant medication, or ongoing nonpharmacologic therapy); 3) Patient Health 
Questionnaire-9 (PHQ-9) score of 5-19 [13]. Exclusion criteria were: 1) Schizophrenia, 
bipolar disease, active delirium, dementia, kidney disease (due to the role of the kidneys 
in magnesium homeostasis), myasthenia gravis (magnesium may worsen symptoms of 
the disease), or gastrointestinal (GI) disease (diarrhea is a common side effect of 
magnesium); 2) pregnant or trying to get pregnant; 3) planned surgery in the next 3 
months; 5) taking a medication known to interact with magnesium; 6) unwilling to stop 




Tablets of MgCl2 (Alta Health Products, Idaho City, ID) were provided free of 
charge. Participants were instructed to take four 500 mg tablets of magnesium chloride 
daily for a total of 248 mg of elemental magnesium per day. MgCl2 was used because of 
its high bioavailability and tolerability compared to other salts [14, 15]. 
Study procedures and randomization 
PCPs reviewed lists of their patients with a diagnosis of depression in their 
medical record and indicated which ones may be sent a letter describing the study. PCPs 
were encouraged to remove patients from their list if they knew depression was no longer 
an active problem, the patient was also suffering from severe mental illness, or the patient 
was not able to start or stop taking magnesium. Those patients that did not opt out after 
receiving the letter were contacted by phone to determine interest and eligibility. 
Eligibility and diagnosis of depression was confirmed with an initial telephone PHQ-9 
score between 5 and 19. Participants next met with study staff for a baseline visit during 
which they provided written informed consent and baseline data including demographics, 
medication use, the PHQ-9 [13], the Generalized Anxiety Disorders-7 (GAD-7) [16], the 
Modified Morisky Scale [17] to assess medication adherence behavior, the PhenX 
Tobacco Smoking Status Questionnaire for Adults, and the PhenX Alcohol 30 Day 
Quantity and Frequency Questionnaire [18]. Randomization to Immediate and Delayed 
treatment was stratified based on PHQ-9 score (5-9, 10-14, and 15-19) and blocked in 
groups of 10. Treatment assignments were sealed in an opaque envelope and shuffled and 
then numbered and opened in that order. The principal investigator (PI) assigned the 
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participants to their randomization order. The PI also gave the volunteers the supplements 
at either week 1 or week 7, based on randomization, and educated each participant on the 
dosage and possible side effects. Data were collected every 2 weeks via telephone and 
included the PHQ-9, GAD-7, questions about changes in medications, changes in 
treatment for depression, and side effects.  
Outcome measures 
The primary hypothesis was that magnesium supplementation decreases 
symptoms of depression and therefore the primary outcome was the difference in the 
change in PHQ-9 scores between baseline and the end of each six-week period 
(difference in differences). The PHQ-9 is a validated questionnaire with high sensitivity 
and specificity for the diagnosis of depression [13]. The PHQ-9 score can range from 0 to 
27, with the following severity scores: 0-4 None; 5-9 Mild; 10-14 Moderate; 15-19 
Moderate to Severe; 20-27 Severe. Telephone administration is comparable to in-person 
tracking [19]. 
Secondary outcomes were exploratory and included changes in the GAD-7 score 
as well as adherence to the supplement regimen and intention to use magnesium 
supplements in the future. GAD-7 score was recorded in the same fashion as the PHQ-9 
and has been shown to be a valid indication of anxiety symptoms [16]. The GAD-7 score 
can range from 0 to 21, with the following severity scores: 0-4 None; 5-9 Mild; 10-14 
Moderate; 15-21 Severe. To assess side effects, participants were asked to compare 
symptoms (headache, diarrhea, nausea, constipation, dizziness, oliguria, and polyuria) to 
baseline using a standardized 0-4 point scale (none, mild, moderate, or severe). At the 
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end of week 12, a pill count was used to calculate adherence to the supplement regimen 
and participants were asked whether they planned to continue using magnesium and why. 
Data analysis 
All data were analyzed based on the intention-to-treat principle. The age and 
gender of patients who were contacted but ineligible were compared to those who were 
randomized. Baseline characteristics of eligible participants were compared by 
randomization group.  Student t-tests or Wilcoxon Rank Sum tests were used for 
continuous values and Chi-square tests for categorical values.  
The change in outcome for each patient was calculated as the last value 
measured during that treatment arm minus the last value measured before that treatment 
arm. Before crossing over, this was the week 6 measure minus the baseline measure. 
After cross-over, this was the week 12 measure minus the week 6 measure. If a week 12 
measure was not available, the week 10 or week 8 measure was used. Participants who 
did not provide at least one outcome measure in each treatment period were excluded. 
Treatment efficacy was assessed as the net improvement in outcome. The mean change in 
the outcomes during the 6 weeks of the control (no treatment) period was compared to 
the change in scores during the 6 weeks of treatment. Linear regression was used to test 
the significance in the net improvement in the outcome while controlling for potential 
confounders. 
Each potential confounder was tested in a separate univariate linear regression 
for association (P<0.05) with the primary outcome and secondary outcome. Potential 
confounders were included in multivariate models. We explored the effectiveness of 
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treatment among various subgroups using multivariate models. Linear regression 
adjusting for randomization and clustering was used to identify adverse effects. Cuzick’s 
test of trend [20] was used to explore the relationships between both the Modified 
Morisky score and treatment response with adherence. A two-sided P<0.05 was 
considered statistically significant. All analyses were completed using Stata14·1 (College 
Station, TX).  
The targeted sample size was based on detection of a difference in difference in 
PHQ-9 scores of 1.5, which was felt to be clinically significant. The calculation, 
assuming a paired t-test, with 84% power, type I error rate of 5%, and a standard 
deviation of 5 [21], resulted in a sample size of 50 participants in each group. 
Results 
Recruitment occurred between June 2015 and May 2016. Of 1,930 patients 
identified from medical records, 1,340 (68%) were contacted and 126 (7%) were eligible 
and randomized (Figure 3.1). The mean age of the contacted patients was 50 years 
compared to a mean age of 52 years in the randomized group (P=0.06). The randomized 
group had fewer males than the other contacted patients (38% vs.47%; P=0.07). 
Sixty-two participants (49%) were randomized to Immediate Treatment and 64 
(51%) to Delayed Treatment (P=0.95). The two groups were similar in all baseline 
characteristics except age. The mean age in the Immediate group was 55.6 versus 49.1 in 
the Delayed group (P=0.006). All participants commenced treatment based on allocation. 
Seven participants withdrew from each group before crossing over (11%) (Figure 3.1). 
The most common reason was a change in other depression treatment (n=7) (Table 3.1). 
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No participants withdrew due to non-compliance. 108 participants completed all 12 
weeks of the study. Four withdrew between week 8 and 12; their last results recorded 
before withdrawal were included in the final sample, resulting in 112 participants 
analyzed (Figure 3.1). The characteristics of the final analyzed sample appear in Table 
3.2. The Immediate group was similar to the Delayed group except that they were 5.1 
years older P=0.04).The characteristics of the 14 subjects who withdrew before crossing 
over were similar in all measured characteristics to the 112 in the final sample except that 
they were more anxious (GAD-7 12.5 vs. 8.6; P=0.01). There were no significant 
differences in age, gender, race, smoking, alcohol consumption, baseline PHQ-9 score, 
Modified Morisky score, or use of depression therapies at the time of randomization. 
Outcomes  
Unadjusted PHQ-9 depression scores improved during magnesium treatment  
(-4.3 points; 95% confidence interval (CI) -5.0, -3.6), but not during the control period  
(-0.1; CI -0.9, +0.7) for the final analyzable cohort of 112 adults. The net improvement 
was -4.2 points (CI -5.4, -2.9; P<0.001). Participants who were randomized to Immediate 
Treatment first experienced a decrease in PHQ-9 score within 2 weeks; their scores 
increased slightly towards baseline during the 6 weeks of control (Figure 3.2). Those in 
the Delayed Treatment group experienced a slight improvement in PHQ-9 score during 
the control weeks and a further improvement during the active treatment.  
 Age, gender, race, smoking status, drinks of alcohol per week, adherence to the 
supplement regimen, and other treatments for depression were not associated with 
response to treatment and were not included in the adjusted model. Mean PHQ-9 change 
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during the control weeks, randomization order, and use of selective serotonin reuptake 
inhibitors (SSRI) were retained in the multivariate analyses. When adjusted for these 
potential confounders, the net improvement with supplementation was -6.0 points (CI -
7.9, -4.2; P<0.001). See Table 3.3. Data for all participants (N=126) follow a similar 
pattern (Table 3.4). Unadjusted GAD-7 anxiety scores improved during magnesium 
supplementation (-3.9 points; CI -4.7, -3.1), but worsened during the control period 
(+0.8; CI +0.02, +1.6) for a net benefit of -4.7 points (CI -6.0, -3.3; P<0.001) (Figure 
3.3). After adjustment for potential confounders (Table 3.3), the net improvement in 
anxiety with magnesium supplementation was -4.5 points (CI -6.6, -2.4; P<0.001). 
Again, the data are similar for all participants as well (Table 3.4). 
Subgroup analyses were performed using the adjusted models of the association 
of magnesium with PHQ-9 and GAD-7 scores. Subgroups were defined  by gender, age 
above or below 55, PHQ above or below 9, GAD above or below 9, use of any 
antidepressant medications, use of specific medications (SSRIs, selective norepinephrine 
reuptake inhibitors, bupropion, monoamine oxidase inhibitors, antipsychotics), use of 
behavioral therapy or counseling, and adherence above or below 80% by pill count. The 
analyses indicated that magnesium was effective in all subgroups (Table 3.3). 
Participants were less likely to report headaches while taking magnesium 
compared to the control period (unadjusted mean headache score 0.41 vs. 0.57 on the 0-3 
scale). The adjusted difference was -0.16 (CI -0.25, -0.03; P=0.013). There was no 
difference in the reporting of diarrhea, constipation, nausea, dizziness or urinary 
symptoms (Table 3.5). Using the adjusted model, we explored the effect of magnesium 
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supplementation on the answers to individual PHQ-9 and GAD-7 items. All items in the 
PHQ-9 improved significantly during active treatment except question 8 (abnormal 
movement speed) and question 9 (thoughts of suicide). Of note, question 9 was positive 
on only 3 of 892 occasions. The only GAD-7 questions that did not improve significantly 
were questions 1 (feeling nervous, anxious, or on edge) and 5 (experiencing restlessness). 
Percent adherence in the Immediate Treatment group (83%) and Delayed 
Treatment group (82%) were similar (P=0.85). Treatment response for both the PHQ-9 
and GAD-7 tended to be greater with increased adherence; however, the trend was not 
significant for either at P=0.19 and P=0.64, respectively.  
When asked whether they would take magnesium in the future, 68 (61%) 
answered yes, 22 (20%) answered maybe and 22 (20%) answered no. The most common 
reasons for a positive answer were “the magnesium helped my mood” (58%) and “it 
helped in other ways” (23%), such as by increasing energy, decreasing constipation, and 
decreasing muscle aches and cramps. The most common reason for a negative response 
was that “magnesium did not help mood” (46%), followed by side effects (20%). The 
most common side effect, diarrhea, was reported by 8 participants.   
Discussion 
This trial was conducted to test the efficacy and safety of over-the-counter 
magnesium and to determine its role in the treatment of depression. Consumption of 248 
mg of elemental MgCl2 daily for 6 weeks improved depression scores by a statistically 
and clinically significant mean of 6 points and anxiety symptoms by over 4 points. This 
effect was not due to natural history, regression to the mean, or confounding, and was 
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seen in a wide range of patients with varying ages, co-treatments, and severity of baseline 
symptoms. The similar effects seen in the univariate and multivariate models indicates 
that the potential confounders had little impact on the estimates of treatment effect.  
As with other studies, [8, 11, 22] the improvement in symptoms was seen within 
weeks. The effect was somewhat diminished within 2 weeks of stopping 
supplementation, indicating relatively quick clearance as well. Although females are 
more likely to be diagnosed with depression [23], there was no difference in effect based 
on gender. The finding that high and low adherence subgroups had similar improvement 
suggests that a smaller dose may suffice with less risk for side effects and lower cost.  
Adverse effects were not so severe as to lead to discontinuation except in one 
case in which nausea and lethargy led to withdrawal after two weeks. Participants did 
report experiencing other clinically significant, and well documented, positive effects of 
taking magnesium, such as decreases in headaches and muscle cramps [24]. The fact that 
nearly all specific PHQ-9 and GAD-7 items improved significantly while on treatment 
corresponds with the qualitative reports.  
Although the association between magnesium and depression is well 
documented, the mechanism is unknown. However, magnesium plays a role in many of 
the pathways, enzymes, hormones, and neurotransmitters involved in mood regulation 
[25]. It is a calcium antagonist and voltage-dependent blocker of the N-methyl-D-
aspartate channel which regulates the flow of calcium into the neuron [26]. In low 
magnesium states, high levels of calcium and glutamate may deregulate synaptic 
function, resulting in depression [9]. Depression and magnesium are also both associated 
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with systemic inflammation [27, 28]. The finding that those participants taking an SSRI 
experienced an even greater positive effect points toward magnesium’s possible role in 
augmenting the effect of antidepressants. Since the mechanism of magnesium’s role in 
depression is still not clear, it is difficult to say why this relationship with antidepressants 
may exist. In a sample of treatment resistant depressed patients with normal magnesium 
levels, those with high normal magnesium levels had a more robust response to 
antidepressants [29]. In another study, severity of depression correlated with reduced 
intracellular magnesium, and cellular levels normalized after successful treatment with 
antidepressants [30]. Patients may have normal plasma concentration of magnesium yet 
have depleted intracellular stores [31]. There may also be differential effects for SSRIs 
compared to other antidepressants. Some evidence to support adjunctive use of other 
nutraceuticals with antidepressants exists. The mechanism may be related to their anti-
inflammatory properties or role in NMDA and glutamate activity [32]. Magnesium 
supplementation may allow for lower antidepressant dosage or avoid the need for use of a 
second medication, both of which could reduce overall side effect burden.  
Implications for Practice 
The net improvement in PHQ-9 score of 6 points is statistically and clinically 
significant. A change in score of 5 or greater reflects a clinically relevant change in 
individuals receiving depression treatment. After 6 weeks of psychological counseling, a 
drop in 5 points from baseline PHQ-9 indicates the treatment response is adequate and no 
treatment change is needed. The same guidelines can be applied to 4 weeks of an 
adequate dose of an antidepressant.[33] Magnesium supplementation provides a safe, fast 
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and inexpensive approach to controlling depressive symptoms. Most patients who 
experience improvement do so within two weeks of starting supplements. Oral 
magnesium supplementation is safe in adults with normal kidney function who are not 
taking medications that interact with the supplement and when used in dosages below the 
upper tolerable limit set by the Institute of Medicine (350 mg elemental magnesium per 
day) [34]. Hypermagnesemia is most commonly associated with the combination of 
impaired renal function and excessive intake of nonfood magnesium; few serious adverse 
effects are reported until very high doses are ingested [34]. 
Similar to national surveys [35], some participants with depression were not on 
any treatment. There are many barriers to treatment for depression including stigma 
associated with diagnosis, cost, side effects, non-adherence, and loss to follow-up [36]. 
Magnesium supplements do not come with the added stigma associated with other 
therapies and, while monitoring response is still important, the risk of side effects is not 
as great as from antidepressants. Over-the-counter magnesium can be offered as an 
alternative therapy to those patients hesitant to begin antidepressant treatment and is 
easily accessible without a prescription for around $14.00 per month.  
Strengths 
This is the first clinical trial done on magnesium for depression in the U.S. 
Exclusion criteria were minimal, increasing generalizability, and it used a well-absorbed 
form of magnesium. The paired analysis allowed each subject to serve as his or her own 
control, minimizing variance and improving statistical power. Random assignment of 
treatment order allowed for controlling for regression to the mean as an explanation for 
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the apparent treatment effects. Enrolling patients over a full year minimized the effects of 
seasonal changes in depression. The withdrawal rate was low and adherence was high, 
confirming patient reports of high acceptability.  
Limitations 
There was no placebo arm and randomization was not blinded for either the 
study team or the volunteer. The use of placebo and blinding are essential for a study that 
seeks to understand the mechanism of action of an intervention. However, they are not 
useful when the research seeks to assess the presence and magnitude of the effect of an 
intervention. Whether magnesium works because it induces a physiological change in the 
subject, or only because of the placebo effect (or a combination of the two), it remains 
that subjects do report better levels of depression and anxiety when taking magnesium 
than when not. 
Enrolling patients with depression listed on their medical chart resulted in 
missing people with undiagnosed depression or who do not use Primary Care. PCPs may 
have introduced selection bias by differentially disapproving patients they thought were 
unlikely to be open to alternative treatments. This may not be an important limitation to 
generalizability since nutraceuticals would probably not be recommended for these 
patients anyway. The low response rate to our letter of invitation and follow up calls may 
have also introduced selection bias. 
The study excluded subjects with malabsorption because the main known side 
effect of magnesium is diarrhea. However, because diarrhea was rare in the study, it 
would be worth determining the tolerance and effect in those with GI disease. Some of 
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the subgroups are small, limiting our ability to detect variation in efficacy, although none 
was seen. Due to the makeup of the local community, the study population lacked racial 
diversity. 
Although improvement in symptoms occurred within two weeks and was 
maintained while on treatment, long-term effectiveness is unknown and longer trials are 
needed.  
Measurement of serum magnesium was outside the scope of the study. A recent 
meta-analysis of observational studies found an overall 1.3-fold increased risk of 
depression in people with hypomagnesaemia [37] yet a previous meta-analysis was 
inconclusive [38]. It is not clear if hypomagnesaemia influences the efficacy of 
magnesium supplementation for depression.  
Conclusions 
Daily supplementation with 248 mg of elemental magnesium as four 500 mg 
tablets of magnesium chloride per day leads to a significant decrease in depression and 
anxiety symptoms regardless of age, gender, baseline severity of depression, or use of 
antidepressant medications. While the cross over design of this trial is robust in 
controlling for internal biases, it would be reassuring to see the results replicated in larger 
clinical trials that test long term efficacy and provide additional data on subgroups. 
However, this efficacy trial showed magnesium supplements may be a fast, safe, and 














These participants were included in the final analysis using their last recorded values. 
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Depression 













Side Effects 1 1 
Change in Health Status 1 1 
Personal Reasons 1 1 
No Reason Given 1 1 2 
Lost to Follow Up 1 1 2 
Total number of 
withdrawals 













Age, mean (SD) 55.2 (12.3) 50.1 (13.0) 0.038 
Male Gender, N (%) 22 (40%) 22 (36%) >0.99 
Self-Report White Race, N (%) 53 (96%) 56 (98%) 0.62 
Current Smoker, N (%) 7 (13%) 8 (12%) >0.99 
Servings of Alcohol Per Week, mean (SD) 3.3 (5.0) 4.9 (7.8) 0.19 
Current Treatment for Depression, N (%) 
No Treatment 14 (25%) 17 (30%) 0.68 
Self-management 1 (2%) 1 (2%) >0.99 
Non-pharmacologic Therapy 14 (26%) 11(19%) 0.50 
One or more medications 35 (64%) 35 (61%) 0.85 
Selective Serotonin Reuptake Inhibitors 19 (35%) 22 (39%) 0.70 
Selective Norepinephrine Reuptake 
Inhibitors 8 (15%) 8 (14%) >0.99 
Tricyclic 2 (4%) 1 (2%) 0.61 
Bupropion 7 (13%) 9 (16%) 0.80 
Monoamine Oxidase Inhibitors  0 0 - 
Antipsychotic 0 2 (4%) 0.50 
Baseline Patient Health Questionnaire-9 
Depression Score, mean (SD) 10.7 (3.7) 10.6 (3.8) 0.84 
Baseline Generalized Anxiety Disorder-7 
Anxiety Score, mean (SD) 8.6 (5.1) 8.7 (5.4) 0.92 
Modified Morisky Score, mean (SD) 2.9 (0.9) 2.9 (1.0) 0.91 
N=number; SD = standard deviation. 
P-values calculated by Chi-square for categorical values and two-sample t-test or Wilcoxon 
Rank Sum for continuous values.  
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Figure 3.2 Patient Health Questionnaire-9 over time by group. 
The individual box plots show the distribution of PHQ-9 scores by week in each  
randomization group. The middle line of each box represents the median score.  
The boxes range from the 25
th
 to the 75
th
 percentile. The whiskers demonstrate the
range of scores with outliers shown by small circles. 
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Table 3.3 Adjusted net improvement with magnesium 
PHQ-9 = Patient Health Questionnaire-9; GAD-7 = Generalized Anxiety Disorder-7; 
CI = confidence interval. 
a
Net Improvement = change in outcome during magnesium treatment – change in 
outcome during control.  
All results adjusted for mean PHQ-9 score during control weeks, treatment order 
 (Immediate vs. Delayed), and selective serotonin reuptake inhibitor (SSRI) therapy. 
PHQ-9 GAD-7 





112 -4.9 -6.0, -3.9 <0.001 -3.6 -4.9, -2.3 <0.00
1 
Control 112 +1.1 -0.1, +2.3 0.08 +0.9 -0.4, +2.1 0.17 
Net Improvement -6.0 -7.9, -4.2 <0.001 -4.5 -6.6, -2.4 <0.00
1 
Subgroups Net 
Improvement 95% CI P 
Net 
Improve
ment 95% CI P 
Gender Female 68 -6.6 -9.1, -4.0 <0.001 -3.8 -6.4, -1.1 0.003 
Male 44 -5.3 -7.6, -3.1 <0.001 -5.5 -8.9, -2.1 0.001 
Age <55 
years 
55 -5.3 -7.9, -2.8 <0.001 -5.1 -8.6, -1.5 0.002 
>55 
years 
57 -6.5 -9.0, -4.1 <0.001 -4.0 -6.6, -1.5 0.001 
Baseline 
PHQ-9 
<9 49 -4.7 -6.3, -3.2 <0.001 -3.1 -4.8, -1.3 <0.00
1 
>9 63 -7.2 -10.1, -4.2 <0.001 -5.6 -9.2, -2.1 0.001 
Baseline 
GAD-7 
<9 68 -4.7 -6.8, -2.6 <0.001 -2.2 -4.0, -0.5 0.005 
>9 44 -8.2 -11.0, -5.3 <0.001 -8.3 -12.6, -3.9 <0.00
1 
Adherence Low 56 -5.3 -8.2, -2.5 <0.001 -3.3 -5.9, -0.6 0.008 
High 56 -6.6 -8.7, -4.6 <0.001 -5.7 -8.7, -2.7 <0.00
1 
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Table 3.4 Unadjusted PHQ-9 and GAD-7 scores by event for all participants (N=126) 






Total Event Immediate Delayed Immediate Delayed  
Baseline, mean 10.9 10.8 10.8 8.9 9.2 9.0 
SD 3.8 3.9 3.8 5.1 5.6 5.3 
N 62 64 126 62 64 126 
Week 2, mean 7.0 9.1 8.1 5.7 8.3 7.0 
SD 4.7 4.9 4.9 4.7 5.4 5.2 
N 60 63 123 60 63 123 
Week 4, mean 5.8 8.9 7.4 4.9 7.8 6.4 
SD 4.3 5.4 5.1 4.4 5.6 5.2 
N 59 61 120 59 61 120 
Week 6, mean 5.1 9.2 7.1 4.4 9.2 6.8 
SD 3.9 5.6 5.2 4.0 5.9 5.6 
N 57 57 114 57 57 114 
Week 8, mean 6.1 6.8 6.5 5.5 6.2 5.9 
SD 4.4 4.9 4.6 4.5 5.5 5.0 
N 55 57 112 55 57 112 
Week 10, mean 6.5 6.6 6.5 5.3 5.8 5.5 
SD 3.9 4.5 4.2 4.3 5.4 4.9 
N 52 56 108 52 56 108 
Week 12, mean 6.3 6.3 6.3 5.2 5.8 5.5 
SD 4.6 5.4 5.0 4.9 5.8 5.3 
N 52 56 108 52 56 108 
SD=standard deviation; N=number 
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Figure 3.3 Generalized Anxiety Disorders-7 over time by group. 
The individual box plots show the distribution of PHQ-9 scores by week in each  
randomization group. The middle line of each box represents the median score. The  
boxes range from the 25
th
 to the 75
th
 percentile. The whiskers demonstrate the range
of scores with outliers shown by small circles. 
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Adverse effect Control Magnesium Difference Difference 95% CI P 
Headache 0.57 0.41 -0.16 -0.14 -0.25, -0.03 0.01 
Diarrhea 0.32 0.29 -0.02 -0.01 -0.11, +0.08 0.79 
Nausea 0.22 0.24 +0.02 +0.02 -0.07, +0.11 0.64 
Constipation 0.20 0.20 +0.00 -0.00 -0.08, +0.07 0.97 
Dizziness 0.24 0.22 -0.02 -0.02 -0.09, +0.06 0.66 
Oliguria 0.04 0.07 +0.03 +0.03 -0.02, +0.08 0.19 
Polyuria 0.11 0.16 +0.05 +0.05 -0.01, +0.11 0.09 
CI = confidence interval. 
a
Mean values of biweekly reports on a 0 to 4 scale. 
b
Adjusted for mean PHQ-9 score during control weeks, treatment order 
(Immediate vs. Delayed), use of SSRIs, 
and clustering within participant. 
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